Biography and Research Information
OverviewAI-generated summary
Bhavana Sridharan's research investigates the physiological and cognitive effects of chemotherapy treatments, specifically focusing on cyclophosphamide, methotrexate, and fluorouracil. Her work examines how these treatments impact the gut microbiome and are associated with depressive-like behaviors. Sridharan has co-authored publications exploring the implications of these chemotherapies on hippocampal-dependent cognition and the gut microbiome, with one publication dating to 2025. Her research network includes collaborators from the University of Arkansas for Medical Sciences, such as Michael S. Robeson and Christa Corley, with whom she shares multiple publications. Sridharan's scholarly output includes 2 publications and has garnered 14 citations, with an h-index of 1.
Metrics
- h-index: 1
- Publications: 2
- Citations: 14
Selected Publications
-
Implications of cyclophosphamide, methotrexate, and 5-fluorouracil chemotherapy on hippocampal-dependent cognition and gut microbiome (2025)
-
Physiological and cognitive changes after treatments of cyclophosphamide, methotrexate, and fluorouracil: implications of the gut microbiome and depressive-like behavior (2023)
Collaboration Network
Top Collaborators
Christa Corley
University of Arkansas for Medical Sciences
2 shared publications
In database
- Physiological and cognitive changes after treatments of cyclophosphamide, methotrexate, and fluorouracil: implications of the gut microbiome and depressive-like behavior
- Implications of cyclophosphamide, methotrexate, and 5-fluorouracil chemotherapy on hippocampal-dependent cognition and gut microbiome
Michael S. Robeson
University of Arkansas for Medical Sciences
2 shared publications
In database
- Physiological and cognitive changes after treatments of cyclophosphamide, methotrexate, and fluorouracil: implications of the gut microbiome and depressive-like behavior
- Implications of cyclophosphamide, methotrexate, and 5-fluorouracil chemotherapy on hippocampal-dependent cognition and gut microbiome
Antiño R. Allen
University of Arkansas for Medical Sciences
2 shared publications
In database
- Physiological and cognitive changes after treatments of cyclophosphamide, methotrexate, and fluorouracil: implications of the gut microbiome and depressive-like behavior
- Implications of cyclophosphamide, methotrexate, and 5-fluorouracil chemotherapy on hippocampal-dependent cognition and gut microbiome
Taylor McElroy
University of Arkansas for Medical Sciences
1 shared publication
In database
- Physiological and cognitive changes after treatments of cyclophosphamide, methotrexate, and fluorouracil: implications of the gut microbiome and depressive-like behavior
Madison Trujillo
University of Arkansas for Medical Sciences (US)
1 shared publication
- Physiological and cognitive changes after treatments of cyclophosphamide, methotrexate, and fluorouracil: implications of the gut microbiome and depressive-like behavior
Pilar Simmons
University of Arkansas for Medical Sciences
1 shared publication
In database
- Physiological and cognitive changes after treatments of cyclophosphamide, methotrexate, and fluorouracil: implications of the gut microbiome and depressive-like behavior
Sangam Kandel
University of Arkansas for Medical Sciences
1 shared publication
In database
- Physiological and cognitive changes after treatments of cyclophosphamide, methotrexate, and fluorouracil: implications of the gut microbiome and depressive-like behavior
Delawrence J. Sykes
Berry College (US)
1 shared publication
- Physiological and cognitive changes after treatments of cyclophosphamide, methotrexate, and fluorouracil: implications of the gut microbiome and depressive-like behavior
Chase Swinton
University of Arkansas for Medical Sciences
1 shared publication
In database
- Implications of cyclophosphamide, methotrexate, and 5-fluorouracil chemotherapy on hippocampal-dependent cognition and gut microbiome
Taylor McElory
University of Arkansas for Medical Sciences
1 shared publication
In database
- Implications of cyclophosphamide, methotrexate, and 5-fluorouracil chemotherapy on hippocampal-dependent cognition and gut microbiome
Justin J. Thomas
University of Arkansas for Medical Sciences
1 shared publication
In database
- Implications of cyclophosphamide, methotrexate, and 5-fluorouracil chemotherapy on hippocampal-dependent cognition and gut microbiome
Beth Cronin
University of Arkansas for Medical Sciences
1 shared publication
In database
- Implications of cyclophosphamide, methotrexate, and 5-fluorouracil chemotherapy on hippocampal-dependent cognition and gut microbiome
Vijayalakshmi Sridharan
University of Arkansas for Medical Sciences
1 shared publication
In database
- Implications of cyclophosphamide, methotrexate, and 5-fluorouracil chemotherapy on hippocampal-dependent cognition and gut microbiome
Similar Researchers
Based on overlapping research topics
Taylor McElory
University of Arkansas for Medical Sciences
Gut microbiota and health
Cancer Treatment and Pharmacology
Pharmacological Effects and Toxicity Studies
Bailey Cronin
University of Arkansas for Medical Sciences
Gut microbiota and health
Cancer Treatment and Pharmacology
Pharmacological Effects and Toxicity Studies
Sofia Syed
University of Arkansas for Medical Sciences
Gut microbiota and health
Cancer Treatment and Pharmacology
Pharmacological Effects and Toxicity Studies
Fang Liu
National Center for Toxicological Research
Gut microbiota and health
Cancer Treatment and Pharmacology
Pharmacological Effects and Toxicity Studies
Pilar Simmons
University of Arkansas for Medical Sciences
Gut microbiota and health
Cancer Treatment and Pharmacology
Pharmacological Effects and Toxicity Studies
William M. Blakemore
National Center for Toxicological Research
Pharmacological Effects and Toxicity Studies
Behavioral and Psychological Studies
Neuroscience and Neuropharmacology Research